Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.48
BATS BZX Real-Time Price
As of 3:05pm ET
 -0.01 / -0.02%
Today’s Change
37.20
Today|||52-Week Range
45.58
+7.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line8.8B4.7B12.8B1.4B
 
 
 
 
 
Depreciation2.2B2.4B2.5B2.5B
 
 
 
 
 
Total Other Cash Flow-1.1B-722.8M-14.9B-1.4B
 
 
 
 
 
Funds From Operations9.9B6.4B360.0M2.5B
 
 
 
 
 
Funds From/For Other Operating Expenses-346.1M-1.1B-2.6B-5.4B
 
 
 
 
 
Net Cash Flow - Operating Activities10.3B7.5B2.9B7.9B
 
 
 
 
 
 
InvestingIncrease In Investments-220.8M-151.5M-152.5M-144.0M
 
 
 
 
 
Decrease In Investments787.8M340.8M1.4B919.1M
 
 
 
 
 
Capital Expenditures-1.9B-2.0B-2.1B-2.1B
 
 
 
 
 
Fixed Asset Disposal3.0B434.7M15.7B228.8M
 
 
 
 
 
Net Assets From Acquisitions -1.3B-1.3B-5.4B--
 
 
 
 
Other Investing - Sources213.0M543.3M360.0M380.8M
 
 
 
 
 
Net Cash Flow Investing-220.8M-3.0B9.0B-1.9B
 
 
 
 
 
 
FinancingShort Term Borrowings-2.9B-2.8B-3.6B129.2M
 
 
 
 
 
Long Term Borrowings3.0B3.2B0.00--
 
 
 
Long Term Debt Reduction-48.6M-37.9M-38.1M--
 
 
 
 
Net Proceeds Stock Sale916.2M275.0M111.3M119.8M
 
 
 
 
 
Common Preferred Redeemed-2.4B-548.3M-151.0M-99.6M
 
 
 
 
 
Common Dividends-5.8B-6.3B-5.9B-6.5B
 
 
 
 
 
Cash Dividends Paid - Total-5.8B-6.3B-5.9B-6.5B
 
 
 
 
 
Other Sources - Financing0.000.00355.4M--
 
 
Other Uses - Financing473.0M358.9M361.5M1.3B
 
 
 
 
 
Net Cash Flow - Financing-7.7B-6.6B-9.6B-7.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-231.8M138.3M-68.6M380.8M
 
 
 
 
 
 
Net Change In Cash2.3B-2.1B2.3B-1.6B